Erickson S K, Shrewsbury M A, Gould R G, Cooper A D
Biochim Biophys Acta. 1980 Oct 6;620(1):70-9. doi: 10.1016/0005-2760(80)90186-1.
A rapid, biphasic inhibition of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase (mevalonate:NADP+ oxidoreductase (CoA-acylating), EC 1.1.1.34) was induced by intragastric administration of R,S-mevalonolactone. The initial phase had a t1/2 of 5.3 min. 30 min after drug administration the inhibition could be reversed in vitro by cytosol or a partially purified cytosolic activator. The reactivation was prevented by 50mM NaF. Thus the initial inhibition appeared to be the result of reversible inactivation possibly by phosphorylation of the enzyme. Consistent with this was the finding that the net reductase activator (phosphatase) activity present in cytosol was decreased 64% in these animals. The rapid reversible inhibition could not be reproduced in vitro by incubating microsomes or postmitochondrial supernatants with mevalonate suggesting the intact cell was necessary for expression of the effect. The second phase of inhibition due to mevalonate administration had a t1/2 of 1.3 h and was not reversible. It was attributed to inhibition of synthesis of reductase probably as the result of sterol accumulation in the cell. Perfusion of 25-hydroxycholesterol through livers isolated from animals at the circadian peak of cholesterol biosynthesis resulted in a rapid, 75-80% inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase. This inhibition was not reversed by incubation with cytosol or partially purified activator. Further, there was no apparent change in net activator levels in cytosol from the livers perfused with 25-hydroxycholesterol. This suggests the effect of this sterol on reductase does not involve reversible phosphorylation-dephosphorylation. On the basis of this study it is postulated that there are at least two mechanisms by which 3-hydroxy-3-methylglutaryl coenzyme A reductase activity can be rapidly suppressed in the intact liver. One is reversible and appears to be the result of alteration in the reductase kinase-phosphatase system. The second is irreversible and may be due to acceleration of the normal degradation system.
经胃内给予R,S-甲羟戊酸内酯可诱导大鼠肝脏3-羟基-3-甲基戊二酰辅酶A还原酶(甲羟戊酸:NADP+氧化还原酶(辅酶A酰化),EC 1.1.1.34)出现快速双相抑制。初始阶段的半衰期为5.3分钟。给药30分钟后,该抑制作用在体外可被胞质溶胶或部分纯化的胞质激活剂逆转。50mM氟化钠可阻止再激活。因此,初始抑制似乎是酶可能通过磷酸化发生可逆失活的结果。与此相符的是,这些动物胞质溶胶中存在的净还原酶激活剂(磷酸酶)活性降低了64%。通过将微粒体或线粒体后上清液与甲羟戊酸一起孵育,在体外无法重现这种快速可逆抑制,这表明完整细胞对于该效应的表达是必需的。由甲羟戊酸给药引起的第二阶段抑制的半衰期为1.3小时,且不可逆。这归因于还原酶合成的抑制,可能是细胞中固醇积累的结果。在胆固醇生物合成的昼夜高峰时,将25-羟基胆固醇灌注到从动物分离的肝脏中,可导致3-羟基-3-甲基戊二酰辅酶A还原酶快速受到75 - 80%的抑制。这种抑制作用通过与胞质溶胶或部分纯化的激活剂一起孵育无法逆转。此外,用25-羟基胆固醇灌注的肝脏的胞质溶胶中净激活剂水平没有明显变化。这表明这种固醇对还原酶的作用不涉及可逆的磷酸化 - 去磷酸化。基于这项研究推测,在完整肝脏中至少有两种机制可使3-羟基-3-甲基戊二酰辅酶A还原酶活性迅速受到抑制。一种是可逆的,似乎是还原酶激酶 - 磷酸酶系统改变的结果。另一种是不可逆的,可能是由于正常降解系统加速所致。